- Forums
- ASX - By Stock
- CTT
- Ann: Cettire Upgrades FY21 Prospectus forecasts
Ann: Cettire Upgrades FY21 Prospectus forecasts, page-41
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTT (ASX) to my watchlist
|
|||||
Last
$1.39 |
Change
-0.040(2.81%) |
Mkt cap ! $528.0M |
Open | High | Low | Value | Volume |
$1.45 | $1.48 | $1.32 | $6.516M | 4.702M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14855 | $1.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.39 | 19000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 865 | 1.405 |
1 | 100000 | 1.400 |
1 | 2000 | 1.390 |
2 | 20400 | 1.385 |
1 | 5400 | 1.380 |
Price($) | Vol. | No. |
---|---|---|
1.360 | 203 | 2 |
1.385 | 192 | 1 |
1.400 | 37869 | 4 |
1.405 | 38400 | 2 |
1.410 | 35000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CTT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online